AzTrials
AzTrials

Nerve BlockNCT03667898

Intelligent Needle Tip Tracking Using Ultrasound Imaging for Lumbar Plexus Blocks

A study testing Lumbar plexus block using NTT and Lumbar plexus block without NTT in people with Nerve Block, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In a randomized controlled crossover study design, ultrasound guided lumbar plexus blocks will be performed with and without the aid of a needle tip tracking (NTT) system. Specialists in anaesthesiology with average experience in ultrasound guided peripheral nerve block (PNB) techniques will perform the blocks. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Nerve Block
What is being tested?
Lumbar plexus block using NTT and Lumbar plexus block without NTT
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27 participants
Where
1 siteNorway
Study dates
8 Oct 2018to 30 Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists (ASA) physical status 1 or 2
  • Volunteers that have given informed written consent

Who cannot join

  • BMI < 18 kg/m2
  • BMI > 35 kg/m2
  • Body weight > 95 kg
  • Volunteers that cannot cooperate during the examination
  • Volunteers that do not speak or understand Norwegian language
  • Volunteers with neurologic disease, nerve- or vascular impairment
Show all 15Show fewer
  • Volunteers with known coagulopathy
  • Volunteers that are allergic to Lidocaine or other local anaesthetic agents
  • Medications at the investigators discretion
  • Volunteers with concomitant medical treatments interfering with PNB treatment
  • Skin disease or infection affecting the whole-body surface or within the area of examination
  • Any reason why, in the opinion of the investigators, the volunteer should not participate
  • Subject participates in a potentially confounding drug or device trial during the course of the study
  • Pregnancy and lactation period
  • Women of childbearing potential who do not use an effective and secure method for birth control

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo University Hospital

    Oslo, 0424

Other trials in Norway

About this study

In a randomized controlled crossover study design, ultrasound guided lumbar plexus blocks will be performed with and without the aid of a needle tip tracking (NTT) system. Specialists in anaesthesiology with average experience in ultrasound guided peripheral nerve block (PNB) techniques will perform the blocks. 27 volunteers will be included. The primary objective is to investigate the effect of the NTT system on performance time, as a measure for improved block performance. Secondary objectives are the effects of the NTT system on dexterity, peripheral nerve block characteristics, subjective experience, and peripheral block performance.

Conditions
Nerve Block
Being tested
Lumbar plexus block using NTT, Lumbar plexus block without NTT

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lumbar plexus block using NTTProcedure or surgery

    An lumbar plexus block is performed using ultrasound guidance with needle tip tracking.

  • Lumbar plexus block without NTTProcedure or surgery

    An lumbar plexus block is performed using ultrasound guidance without needle tip tracking.

Study groups in NCT03667898
Study groupRoleWhat they receive
Active needle tip trackingExperimentalA needle tip tracking system is used when performing an ultrasound guided lumbar plexus block.
Receives: Procedure: Lumbar plexus block using NTT
Inactive needle tip trackingOtherNo needle tip tracking system is used when performing an ultrasound guided lumbar plexus block.
Receives: Procedure: Lumbar plexus block without NTT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance time

    Performance time is defined as the time from insertion of the block needle (skin puncture) until finishing local anaesthetic (LA) injection

    Measured: During peripheral nerve block procedure

Secondary outcomes (9)
  1. Distance travelled by needling hand

    Measured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection

    Measured: During peripheral nerve block procedure

  2. Distance travelled by probe hand

    Measured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection

    Measured: During peripheral nerve block procedure

  3. Number of intended movements (needling hand)

    Measured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection

    Measured: During peripheral nerve block procedure

  4. Number of intended movements (probe hand)

    Measured by motion analysis from insertion of the block needle (skin puncture) until finishing LA injection

    Measured: During peripheral nerve block procedure

  5. Block success

    A sensory block is defined as successful when there is analgesia (no sensation for touch) or anaesthesia (no sensation at all) involving all five nerves distal to the elbow

    Measured: 30 minutes after peripheral nerve block procedure

  6. Block onset time

    Block onset time is defined as the time between the end of LA injection and development of a successful sensory block

    Measured: Within 30 minutes after peripheral nerve block procedure

  7. Block duration

    Block duration is the time from the end of LA injection until at least one of the nerves involved in the sensory block has recovered

    Measured: Within 240 minutes after peripheral nerve block procedure

  8. Quantified discomfort during block performance

    The participants are asked about discomfort during the block procedure using a numeric rating scale (scale range 0 - 10; 0 = no discomfort; 10 = worst discomfort imaginable)

    Measured: Immediately after peripheral nerve block procedure

  9. Confidence in block success

    The anaesthetist is asked if he expects the block to be successful using a numeric rating scale (scale range 0 - 10; 0 = block success unlikely; 10 = block success very likely)

    Measured: Immediately after peripheral nerve block procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2018
  2. Study start8 Oct 2018
  3. Primary completion26 Oct 2018
  4. Study completion30 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03667898
Sponsor's protocol ID
2018/1100
Status last verified
Dec 2018
First submitted
7 Sep 2018
Last updated
12 Dec 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Lumbar plexus block using NTT and Lumbar plexus block without NTT in people with Nerve Block, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance time (time frame: During peripheral nerve block procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in